Bristol Myers Squibb Patient Assistance Foundation
Uninsured patients with household income up to 500% of the Federal Poverty Level (FPL) qualify for free nivolumab (Opdivo) through the BMS Patient Assistance Foundation. Apply online or by phone; approval typically takes 3-5 business days, covering up to 12 months with renewals.[1]
BMS Access Support Program
This offers copay assistance for commercially insured patients, but uninsured patients can get connected to the foundation program or other free drug options. Call 1-888-423-5220 for uninsured eligibility screening and navigation to state programs or clinical trials.[1][2]
Patient Access Network (PAN) Foundation
PAN provides up to $10,800 per year for uninsured or underinsured oncology patients, including nivolumab, if income is 400-500% FPL and they face treatment delays due to costs. Applications are online; funds deplete quickly, so apply early.[3]
HealthWell Foundation
Covers copays and premiums for uninsured cancer patients on nivolumab with income up to 500% FPL. Grants up to $15,000 annually; requires proof of financial hardship. Open enrollment periods apply—check website for nivolumab status.[4]
NeedyMeds and RxAssist Options
These directories list additional nivolumab-specific aid:
- Partnership for Prescription Assistance connects uninsured to BMS programs.
- RxAssist highlights state pharmaceutical assistance programs (e.g., California's) that may cover nivolumab for uninsured low-income residents.
Search by ZIP code for local eligibility.[5][6]
How to Apply and Eligibility Tips
Most programs require proof of income, no insurance, U.S. residency, and a prescription. Start with BMS Access (fastest for Opdivo) or PAN/HealthWell for broader cancer funds. Approval rates exceed 80% for qualifying uninsured; reapply annually. Clinical trials via ClinicalTrials.gov offer free nivolumab access without income limits.[1][7]
[1]: BMS Access Support
[2]: BMS Patient Assistance Foundation
[3]: PAN Foundation - Oncology
[4]: HealthWell Foundation - Cancer
[5]: NeedyMeds - Nivolumab
[6]: RxAssist
[7]: ClinicalTrials.gov - Nivolumab